scimus quid non scimus
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"OMQ"This Self Expression cometh "Coullddaa,Woullddaa"...
this is real true 2 to most flippants as they try,to time and tickle trade for some atm$.
For a Small Retail-Trader,lets' see later if you profit more tickle trading it rather than bagholding it till summer and beyond...with 50K shares or 100Kshares...when pps gets to DollarLand.
I watch the QNTA-Tape as I Trade on the BigBoards daily.
The more you Trade,The Less you make eoy.
Multi-Millions of People still hesitant to get Vaccinated including myself and just Like them, I don't like a Synthetic Compound getting injected into my body...as Nobody knows really what happens 3 years after.
https://www.msn.com/en-us/news/world/cascade-of-rare-complications-deepen-india-s-covid-misery/ar-AAKbUSJ?ocid=msedgntp
MedolifeRx Escorine® may get and FDA EUA.(ynk)
Stay Course on your Aim for you will Greatly Be Rewarded...as True Investors Onboarding exponentially Growing.
The Dollar Dream 4 YOLO will Come.
Just the other day and OTC that Filed for COVID-19 Trials Therapy was Rebuked by the FDA (did not met the Protocols),but the Company still managed to Partner with a Pharmaceutical Company in India,and the OS/Float
is about 3X that of QNTA with a Mkt Cap now of $1.2B
QNTA Current Mkt Cap is Totally SuperDuper Undervalued.
A Gallon of Blue Scorpion Venom Extraction when Published will move the PPS Trading Level overnite.
With All the Current and Upcoming Catalyst and Rolling-in Updates,,,the Dollar Dream will Potentially be Achieve this Summer.jmhtto
Homeopathy Products and Remedies Gain Popularity amidst COVID-19 Crisis
The newly circulating COVID-19 (Coronavirus) has created an unprecedented demand for homeopathy products.
Medolife is conducting clinical trials on Escozine(R) as a treatment for COVID-19 in both the United States and the DR.
The Company has completed an Investigational New Drug (IND) filing on Escozine(R) through the US Food and Drug Administration (FDA) and is awaiting a response after submission of its final data set.
Escozine(R) recently received renewed product registration in the DR, enabling it to be sold as a natural alternative medicine for the treatment of cancer throughout Latin America.
"For many pharmaceutical companies, getting to a Phase II trial can take decades due to many formulation adjustments, bad outcomes and redesigning of program constructs.
...and the trial should take only a short time once approved.eom
Huge News!!!
https://www.barchart.com/story/news/1737363/medolife-rx-completes-initial-meeting-with-bioethics-committee-preparing-for-commencement-of-phase-ii-clinical-trial-on-lead-drug-candidate
Medolife Rx Completes Initial Meeting With Bioethics Committee, Preparing For Commencement Of Phase II Clinical Trial On Lead Drug Candidate
via NewMediaWire - Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCPINK:QNTA), announced today that it completed its initial meetings with CONABIOS, the medical ethics committee that oversees all clinical trial programs in the Dominican Republic (DR).
The meeting outlined the next steps in its clinical program on Escozine(R) as a treatment for the SARS-CoV-2 (COVID-19) virus and the Company is seeking approval to commence clinical trials.
The Company has completed significant preclinical safety and efficacy trials in the DR, which included more than 500 participants.
The results of those studies demonstrated the efficacious nature of Escozine(R) in fighting viral infections, specifically in COVID-19 patients, where data showed a reduction in severity and duration of symptoms as well as a decrease in the length of positive tests. Additionally, throughout the preclinical trials, no patients experienced adverse effects to the drug candidate at any dosing level, establishing that the drug is safe and non-toxic.
This data was submitted to the Ministry of Health, which led to not only the re-registration of Escozine(R) as a natural alternative medicine in cancer treatment, but enabled the Company to seek medical ethics committee approval to begin Phase II human trials on Escozine(R) as a COVID-19 therapeutic.
QNTA:First Commercial Licensing Agreement...
https://finance.yahoo.com/news/quanta-announces-first-commercial-shipment-123100387.html
It is our first commercial product licensing deal, and we look forward to a long-term mutually beneficial relationship with RST Sanexas. We anticipate follow-on orders as well as additional licensing agreements from others for our potent and proprietary technology in the form of plant-based ingredients used in products throughout the health care and pain management product spectrum."
RST Sanexas
https://www.rstsanexas.com/science
Once FDA IND is Cleared and Hit The Leading NewsLines for Escorine®
Distribution in the US of A. BoomTime!!!
I CONCUR 5000% of your Assessment PB.eom
The FDA IND of Escozine® upon Approval,essentially allowing the drug to be distributed in the US.
After such designation, the Company will pursue other clinical applications of Escozine®, including as a potential cancer therapeutic where the Company has already released positive clinical results.
https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html
Too Bad PB that a few here have a problem in comprehending or understanding
this recent news...or prolly not reading it entirely befor spouting something they don't understand.
So many links for DD were and are provided here. but these miscreants are getting into the Board Discussions with a Pebble mind...lol
The True Investors (successful-winners) of Kryptos are those who got into the Programs 2 or 5 years ago...these investors if they bagheld it to this year's Bonanza are now Millionaires,Sold and Happily enjoying Life somewhere...on Earth.
Current Traders of these coins/tokens are just after atm$, most of them are getting scammed from hackers.
Multi-Billion of Dollars went pooffed just a few hours ago...due to krazzyyy Volatility.
Now,A Retail currently purchasing QNTA shares and bagholding it and Patiently waiting for the Big Fat WinFall while in PennyLand are the "True Investors".
Later those who will be coming and chasing it in the DollarLand, will just be after atm$...while the "True Investors" will be Banking...Me myself including...and many more here and somewhere out there.
So many BioTech Companies out there you can look @...but very Rare..if you can Find one Like MedolifeRx.
Any Small Trader buying a BTC.X or DOGE.X @ current prices,will need Escozine-HP or Escozine® soon or later
for their Health problems developing from Anxiety,cancer or Vitiligo.jmhpo
Buy,Hold for Huge WinFall or Flip for some Tickles...if you can maintain it without missing 4 a YOLO ahead.
PS:Think of a Current Household name from Pennyland...that are now Worth Multi-Billion Dollars in Mkt Cap.
Note:This is Not a DM 2 you CJ.tx
News "2"morrow,Rhopalurus Princeps.(pchnr).eom
Moohhlaa!2 Me: My 3 LongTerm BigBoard (bagholders) are All Hulkee Green,
#1 A BioTech Co.,was Recently FDA IDE Breakthrough Device Approved..with it's first and only one of it's kind in the whole world for CRC.
#2 is a Software Application Co.,especializing in IoT,Data Intelligence,and multiple..SmartSolutions
#3 An On-line Apparel Brand Retailer with B&M Stores Co.,with a World Famous Brand on QVC Shopping
Great DD + Bagholding Truly Pay$ Great.
Be back here later.
Have a Great Day Accumulating.
The QNTA Jumbo Jet (Fully Loaded with Escozine® and Blue Scorpion Venom is Currently @ Punta Cana Airtport Taxiway heading to the Runway...awaiting Clearance "4" Take-off for it's Essential Maiden Flight to the US of A, Carrying Treatment Relief for the Cancer Patients.
Savvy Investors with a lot of "Pay-with-Cents" Patience and Accumulating Shares @ Current Super Undervalued/sh will be Greatly Rewarded...pretty soon.
QNTA Future is Truly Bigger Than Huge....Company got the Whole Pizza-Enchilada. The DD is one of a Kind in PinkyLand and Better Than Great Compared to a Lot of BigBoard BioTechs still in Mouse Clinical Trials but already Trading in Multi-Dollars.
Plenty of Catalyst Rolling into the SummerTime.
QNTA All the Way!!!
More and More People are Suffering and Dying with Various kinds of Cancer Due to All Kinds Toxic Chemicals used in Farming,Food Processing,Material Handling and Synthetic Drugs Formulations... and Pollution in the Air Due to Hefty Carbon Footprint of BitMining as One Example.
It's Great that We Have a Mad Scientist (Dr. Arthur Mikaelian) with a Beautiful Mind recently receiving Achievement Award for Work on COVID-19
Treatment...the Current Dreaded Pandemic Disease with No Known Efficacy higher than Escozine® based on the recent published/approved and on-going trials Synthetic Based Compounds.
Once you Accumulated your Share Amount Goal, get a Blue Scorpion Tattoo just like the Woman who Survived Late Stage IV Cancer Survivor given with just 3 months to live Notice from Doctors milking Her thousands n thousand of $ for so long with Drugs based with Synthetic Compounds.jmko
HODL 4 YOLO if u havn't achieved one yet.
Invested here with No Tickle Trading for atm$...I do this on the BigBoards.
Will bite another block again today.
Hulkee Green Days here @ hand.jmhtto
EUROMED FOUNDATION: Treatment Methods BLUE SCORPIION VENOM
https://euromedfoundation.com/en/procedures/treatment-methods/blue-scorpion-venom
HOW BLUE SCORPION VENOM WORKS
Researchers investigating the use of blue scorpion venom as a cancer treatment have identified certain chemicals, called peptides, contained in the venom that can help destroy cancer cells and avoid the side effects of chemotherapy and other conventional cancer treatments. The peptide, chlorotoxin, is the same chemical that paralyzes a scorpion’s prey. In one study, published in 2015 by Science Daily, researchers found that these peptides bind specifically to cancer cells and shrink and destroy them.
An 8-year clinical study conducted by one of the companies that markets a blue scorpion venom cancer drug reported a 90% success rate for more than 8,000 patients with various forms and severity of the disease.
OUR BLUE SCORPION VENOM HOMEOPATHIC VERSION
A handful of companies produce scorpion venom drugs that are marketed under specific brand names. At EuroMed, we prepare our own homeopathic remedy using technology that enables us to customize the dilution, so the treatment is safe and tailored to each patient’s specific needs.
COMPLEMENTARY THERAPY
When used as a complementary therapy for treating cancer, blue scorpion venom can improve the quality of a patient’s care in many ways:
Pain relief
Improved sleep quality
Strengthened immune system
Better appetite
Increased weight
Heightened physical, mental, and emotional state
Additionally, the blue scorpion venom can drive tumor activity into remission and increase a patient’s life expectancy.
Blue Scorpion Venom is in Demand Indeed.
Patent for Vitiligio:US 2017/0100441 A1
https://patentimages.storage.googleapis.com/15/2a/0a/ce93c3cd19cf16/US20170100441A1.pdf
Abstract
A composition for treating vitiligo and a method of making
the same, said composition comprising: a blue Scorpion
venom; and an alpha lipoic acid.
Preferably,
the Blue Scorpion Venom is diluted, polarized, and nanosized. Preferably
the alpha lipoic acid is polarized and nanosized. The com
position may also comprise various vitamins and minerals.
Vitiligo
https://www.mayoclinic.org/diseases-conditions/vitiligo/symptoms-causes/syc-20355912
Lo and Behold:The Rise of The Blue Scorpion Venom is @ hand.eom
Medolife has been researching Escozine® as a potential treatment for COVID-19 in clinical research programs in both the United States and the DR.
The Company has completed an Investigational New Drug (IND) filing on Escozine® through the US Food and Drug Administration (FDA) and is awaiting a response.
In the DR, and upon approval from the medical ethics committee, it will commence a double-blind placebo human study on Escozine®, which would mark a substantial step forward in Escozine's path toward worldwide registration and adoption.
https://newsfilter.io/a/3216e51dd6b440faffe147f9be46e438
This Answers All The Speculations.
News:QNTA Receives Achievement Awards From Regulatory Agency in the Dominican Republic for Work on COVID-19 Treatment.
https://newsfilter.io/a/3216e51dd6b440faffe147f9be46e438
BURBANK, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc.
(OTC:QNTA), announced today that its CEO Dr. Arthur Mikaelian received an achievement award from the "Defensa Civil Republica Dominicana" (The National District of Civil Defense) for his unconditional support of the cause of the agency and his work on Escozine® as a treatment for the SARS-CoV-2 (COVID-19) virus in the Dominican Republic (DR).
The award was formally presented at a ceremony on Friday, May 14, where local leaders, such as the mayor, attended to recognize Dr. Mikaelian for his work.
"If Something went wrong" as you are implying...
The Fact that...No News update regarding the outcome of the IND from the FDA yet...it means No News is Good News about it.
Normally,The FDA will send a Hold Notice/Letter No more than 30 Calendar Days from the Day the IND submission-received by the Agency...if they need more documents/data etc from QNTA.
I am following 2 Biotech companies that received a"HOLD" Letter from FDA
for their IND for Phase i Clinical Trials...as the Agency more Data/docs etc.
Read and understand what this News means...
Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html
This data, as well as the batch of Escozine® that was produced specifically for the FDA, has now been submitted. After the review of the data and barring any further inquiries or requests, the FDA will designate IND status for Escozine®, essentially allowing the drug to be distributed in the US.
After such designation, the Company will pursue other clinical applications of Escozine®, including as a potential cancer therapeutic where the Company has already released positive clinical
results.
Pay attention and Connect those colored Blue lines as one Sentence.
Is your palm getting itchy?then a News is @ hand in a few hours.::)))
Let's Review QNTA FDA IND Submissions History...
January 21, 2021
https://finance.yahoo.com/news/medolife-rx-inc-submitted-applications-124900594.html
Medolife Rx, Inc. Has Submitted Applications Of Their Scorpion Venom To Help Fight Against Cancer And COVID-19 With The FDA In The Dominican Republic; The FDA Is In The Process Of Investigation And Conducting Their Due Diligence For Efficacy And Safety
March 25,2021
(PIND #150335)
https://finance.yahoo.com/news/medolife-rx-completes-batch-production-130000438.html
Medolife Rx Completes Batch Production of Escozine® for FDA Submission
April 13,2921 (PIND #150335)
https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html
Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
What's Next?
We are All Waiting!!!
QNTA Investors/Traders...
If your "Ring Finger" is Longer than your "Index Finger"...It means you Will be "Successful" here.
Rubbr2 Click Open the FDA IND Application Overvew Link again.It Clearly Stated 30 days "Not" 30 business days
https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-overview
An IND application may go into effect:
30 days after FDA receives the application, unless FDA notifies the sponsor that the investigations described in the application are subject to a Clinical Hold; or
on earlier notification by FDA that the clinical investigations in the IND may begin.
MedolifeRx:Will be a Potential Big Pharma BO...as it will be Cheaper for Them to Acquire The Whole Pie. Research/Pre-clinicals Toxicity/Efficacy Everything are already Done with Production and Distribution in Place.
For Future Insti-Buyers, it will be like Purchasing @ $5/sh equivalent to
Retail Investors...purchasing now @ $0.10/sh
5Gls/yr will soon be Realize and Sustainable with their recent Facility Expansion...
Including onboarding of Scientific Team and a 2nd Shift Production Team as well.
Stellar Management Team-Comprised of Experts
http://medolife.com/about/team/
US Patent:#US 8,097,284 B2 Granted in 2012
FDA IND (PIND #150335) awaiting 8K
95%-98% Efficacy for CV-19 and Cancer Treatment per Trials Conducted @ US and DR Research Facilities.
OTC Current and Low SS
No Promos
Escozine®
Escozine-HP™
Quanta Products for Mucle Pain,Beauty & Wellness Available On-Line
Immunapen
$10K/CC of Blue Scorpion Venom for the Big Pharmas, Research Labs/Centers
(OT)RB2..I addressed Human Being (as 95% are nice, gentle n kind)as YoungMan or YoungLady @ Certain of Age with a HS or GED Certificates.
but Not 2 People as Most are 95 % A$hole% in many ways. if u get my drip.
I traveled extensively all over the World or Drove around the Whole Cali4nia and most of Continental US of A,,,and I have met All Human and People of Various Etnicities n Races.
I don't judge anyone Irregardless of Skin Color and Beliefs.
Still Plenty of Places 4 to go around in America but Not the US.
PS:People borne in the US thinks..they are Americans...Not True...as they are Only US CitiZens...
Everyone Holding a Signed Blue Passport to themselves are "Americans"...as when in a Foreign Country.
You are Welcome...YoungMan.Keep On Reading...if you have Questions...this is Great for you...eliminating your Doubts to Invest with Medolife Enormous
Future.
Buy n HODL "4" YOLO.jmhtto
This is My only Current OTC Pick for this year...It meets All the Credentials that I and my Associates are Looking for and have Done in depth DD on it.
Build your Fortune,Be Resourceful,Invest Wisely with your own Personal DD.
Have a Geat Day.
PS:QNTA is Prestine,Super Clean,No Promotions and very very Astute in Releasing their PR's aside from being OTC Current.
ReRead that FDA IND 30 Day "OVERVIEW" again and again until it Clicks...
IND Application Procedures: Overview
https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-overview
Been over 30 Days..
Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html
Nothing you,Me and Them Can do @ this moment...but "2" Wait.
ReRead this portion of the recent News...The FDA will designate IND status for Escozine®, essentially allowing the drug to be distributed in the US.
https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html
After such designation, the Company will pursue other clinical applications of Escozine®, including as a potential cancer therapeutic where the Company has already released positive clinical results.
Very Very Clear to Understand and Comprehend what it Truly means Regarding this much awaited and well Anticipated FDA IND Approval news @ hand.
1) Essentialy Allowing Escozine® to be Distributed in the US.
2) To pursue Clinical Applications of Escozine®,including as a potential
cancer therapeutic where the Company has already released positive
clinical results.
Your Option 3 is "Not" Valid anymore...as the 30Day FDA IND Waiting Period is Over.
Play Detective here below Links..
https://www.bing.com/search?q=FDA+IND+Waiting+period&cvid=151765c171ef4d71b99a3e88d7533129&aqs=edge..69i57.14480j0j1&pglt=427&FORM=ANNTA1&PC=W069
IND Application Procedures: Overview
Upon receipt of an IND application, FDA will notify the sponsor of the date it receives the application through an IND acknowledgment letter.
An IND application may go into effect:
30 days after FDA receives the application, unless FDA notifies the sponsor that the investigations described in the application are subject to a Clinical Hold; or
on earlier notification by FDA that the clinical investigations in the IND may begin.
Once an IND application is in effect, a drug manufacturer may ship the investigational new drug to the investigator(s) named in the application. An investigator may not administer an investigational new drug to human subjects until the IND application goes into effect.
I Concur 5K% DragonLady. Potential Return to Investors will be Enormous.
One Huge Catalyst is "2" Buy and HODL with Great Patience to 8.eom
Mr."NO VALUE" u got my Iggy Button EscozineNergize on.eom
QuietNTrulyAwesome like Miss DR 4th Pl 2021 MU
Pageant.
QNTA got a Great follow-up Review @ InsiderFinancial and Investors/Traders Sentiments rising Exponentially @ Popular SM Platform MB's.
On May 11th, QNTA announced a shakeup in its management team. Philip Sands is stepping down from the role of President.
He is being replaced on an interim basis by Medolife CEO Dr. Arthur Mikaelian who will also serve as Chairman of the Board.
Even though it was a planned step in the merger process, the headline also shook up the investment community because it was perceived as a step in the right direction.
It sparked a strong volume run above $0.15 that could mean the previous peak of $0.20 is not far away.
So, while QNTA is widely perceived as a COVID-19 play, investors also get exposure to the oncology space.
In pre-clinical studies, Escozine in combination with chemotherapy was found to be effective in killing leukemia and lymphoma cancer cells.
Investors are hoping for good news from the FDA regarding the advancement of Escozine for COVID-19.
If the new leadership structure can deliver on this potential catalyst, QNTA is likely to explode.
In the meantime, momentum is in this stock’s favor.
QNTA:"Bull-Southern Cross" will be Painted 2day.eom
QNTA Investors @ Current pps Shall/Will get a Dream-Boat/RV's or any kind of Outdoor Toys...to all...who likes "2" go Fishing or Camping somewhere.
A trip "2" Gods Bath River/Trail shall be Great when the H20 Temp gets warmer...
QNTA all the way up!!!
Escozine® Will get RecogniZation from Big Pharmas Top Scientist-Researchers,Insti-Investors,Retail-Investors,Traders and Bloggers...as Krep2's melted down heavily and Multi-Billions poofed into smoke this weekend.
Miss DR U was 4th place...Imagine She Won and become QNTA Product Endorser.
Big and Great Days ahead...as aplenty of Catalyst are Line-up n Rollin in Fullspeed into the Summertime.